• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及ESNA检疫医院患者样本中COVID-19的特征、结局及严重程度指标:一项回顾性研究

Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital's Patients, Egypt: A Retrospective Study.

作者信息

Ghweil Ali A, Hassan Mohammed H, Khodeary Ashraf, Mohamed Ahmed Okasha, Mohammed Haggagy Mansour, Abdelazez Ahmed Alyan, Osman Heba Ahmed, Bazeed Shamardan Ezzeldin S

机构信息

Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, South Valley University, Qena 83523, Egypt.

Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena 83523, Egypt.

出版信息

Infect Drug Resist. 2020 Jul 17;13:2375-2383. doi: 10.2147/IDR.S263489. eCollection 2020.

DOI:10.2147/IDR.S263489
PMID:32765012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7381791/
Abstract

BACKGROUND

The risk factors, disease characteristics, severity, and mortality of COVID-19 are unclear, particularly in Egypt.

OBJECTIVE

The objective was to analyze the patients' characteristics, hematological, biochemical, and chest imaging findings among the cohort of patients with COVID-19 in Egypt and also to shed light on the predictors of COVID-19 severity.

PATIENTS AND METHODS

A retrospective study was conducted on 66 patients with COVID-19 in Egypt. Medical history, imaging data (CT chest findings), and measured hematological and biochemical parameters at diagnosis were recorded in the form of complete blood counts and differential counts; CRP, ESR, serum ferritin, creatinine, and liver function tests . Results of real-time reverse transcription-polymerase chain reaction (rRT-PCR) for detection of SARS-CoV-2 RNA at diagnosis and during follow up of these patients were also recorded.

RESULTS

The study included 36 patients with mild to moderate COVID-19 and 30 patients with severe/critical infection. There was a significant older age among severe (62.6 years old ±10.1SD) than mild to moderate infection (55.5 ± 10.1) (˂0.05). Fever, dry cough, dyspnea, and sore throat malaise were highly frequent among COVID-19 patients, while headache and diarrhea were the least frequently occurring manifestations. All included cases (30 patients, 100%) with severe COVID-19 showed crazy-paving appearance (in the form of reticular and/or interlobular septal thickening) with or without GGO. There were significantly lower mean values of WBCs, lymphocytic count, total protein, and albumin among the severely infected than those who had mild to moderate COVID-19 infection, ˂0.05 for all. Additionally, there were significantly higher mean values of CRP, ESR, ferritin, ALT, and AST among patients with severe/critical COVID-19 when compared with those having mild to moderate COVID-19, ˂0.05 for all.

CONCLUSION

Among the studied demographic, clinical, hematological, biochemical, and imaging data, dyspnea, diabetes mellitus, lymphopenia, raised CRP, ESR, ferritin, ALT, AST, low albumin, and presence of CT chest findings could be considered as predictors for COVID-19 severity using binary logistic regression analysis.

摘要

背景

新型冠状病毒肺炎(COVID-19)的危险因素、疾病特征、严重程度和死亡率尚不清楚,尤其是在埃及。

目的

分析埃及COVID-19患者队列的患者特征、血液学、生化和胸部影像学表现,并阐明COVID-19严重程度的预测因素。

患者与方法

对埃及66例COVID-19患者进行回顾性研究。以全血细胞计数和分类计数、CRP、ESR、血清铁蛋白、肌酐和肝功能检查的形式记录病史、影像学数据(胸部CT表现)以及诊断时测得的血液学和生化参数。还记录了这些患者诊断时和随访期间检测SARS-CoV-2 RNA的实时逆转录-聚合酶链反应(rRT-PCR)结果。

结果

该研究包括36例轻度至中度COVID-19患者和30例重度/危重症感染患者。重度患者(62.6岁±10.1标准差)的年龄显著高于轻度至中度感染患者(55.5±10.1)(P<0.05)。发热、干咳、呼吸困难和咽痛不适在COVID-19患者中非常常见,而头痛和腹泻是最不常见的表现。所有纳入的重度COVID-19病例(30例患者,100%)均表现为铺路石征(呈网状和/或小叶间隔增厚形式),伴或不伴磨玻璃影(GGO)。重度感染患者的白细胞、淋巴细胞计数、总蛋白和白蛋白的平均值显著低于轻度至中度COVID-19感染患者,所有指标P均<0.05。此外,与轻度至中度COVID-19患者相比,重度/危重症COVID-19患者的CRP、ESR、铁蛋白、ALT和AST的平均值显著更高,所有指标P均<0.05。

结论

在研究的人口统计学、临床、血液学、生化和影像学数据中,使用二元逻辑回归分析,呼吸困难、糖尿病、淋巴细胞减少、CRP升高、ESR升高、铁蛋白升高、ALT升高、AST升高、低白蛋白以及胸部CT表现可被视为COVID-19严重程度的预测因素。

相似文献

1
Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital's Patients, Egypt: A Retrospective Study.埃及ESNA检疫医院患者样本中COVID-19的特征、结局及严重程度指标:一项回顾性研究
Infect Drug Resist. 2020 Jul 17;13:2375-2383. doi: 10.2147/IDR.S263489. eCollection 2020.
2
Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt.埃及第二波和第三波大流行期间 COVID-19 患者的人口统计学、临床和实验室特征。
J Infect Public Health. 2021 Oct;14(10):1358-1366. doi: 10.1016/j.jiph.2021.08.009. Epub 2021 Aug 14.
3
Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt.埃及法尤姆大学医院轻症和重症 COVID-19 患者的临床和胸部计算机断层扫描特征。
PLoS One. 2022 Jul 8;17(7):e0271271. doi: 10.1371/journal.pone.0271271. eCollection 2022.
4
Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study.三组中COVID-19逆转录聚合酶链反应阳性有症状患者的临床、血液学和放射学参数评估:一项比较研究
Cureus. 2023 May 30;15(5):e39681. doi: 10.7759/cureus.39681. eCollection 2023 May.
5
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
6
[Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].新型冠状病毒肺炎患者胸部CT评分的时空分布及预测价值
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):230-236. doi: 10.3760/cma.j.cn112147-20200522-00626.
7
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt.新冠病毒肺炎患者严重程度及合并感染抵抗情况的预测因素:上埃及地区的首份报告
Infect Drug Resist. 2020 Oct 5;13:3409-3422. doi: 10.2147/IDR.S272605. eCollection 2020.
8
Role of Hematological and Immunological Parameters in COVID-19 Patients.血液学和免疫学参数在新冠肺炎患者中的作用
J Pharm Bioallied Sci. 2021 Apr-Jun;13(2):238-243. doi: 10.4103/jpbs.JPBS_655_20. Epub 2021 May 26.
9
Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients.病毒载量与COVID-19患者临床和生化特征的相关性
Cureus. 2021 Jul 27;13(7):e16655. doi: 10.7759/cureus.16655. eCollection 2021 Jul.
10
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.摩洛哥卡萨布兰卡新冠肺炎患者严重程度的预测因素
Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716.

引用本文的文献

1
A Comparative Analysis of Laboratory Parameters of Hospitalized COVID-19 Patients by Disease Severity and Mortality at a Facility in Ibadan, Nigeria.尼日利亚伊巴丹一家医疗机构中按疾病严重程度和死亡率对住院COVID-19患者实验室参数的比较分析
Niger Med J. 2023 May 11;64(2):243-250. eCollection 2023 Mar-Apr.
2
Role of epinephrine in attenuating cytokine storm, decreasing ferritin, and inhibiting ferroptosis in SARS-CoV-2.肾上腺素在减轻细胞因子风暴、降低铁蛋白以及抑制新型冠状病毒中的铁死亡方面的作用。
Egypt Heart J. 2024 Feb 20;76(1):22. doi: 10.1186/s43044-024-00455-9.
3
Predictors of mortality among inpatients in COVID-19 treatment centers in the city of Butembo, North Kivu, Democratic Republic of Congo.刚果民主共和国北基伍省布滕博市新冠病毒治疗中心住院患者的死亡预测因素
PLOS Glob Public Health. 2024 Jan 24;4(1):e0002020. doi: 10.1371/journal.pgph.0002020. eCollection 2024.
4
The Impact of Effective Vaccination on Clinical and Radiological Involvement in COVID-19 Patients.有效疫苗接种对新冠病毒肺炎患者临床及影像学表现的影响
Medeni Med J. 2023 Dec 26;38(4):260-267. doi: 10.4274/MMJ.galenos.2023.88655.
5
Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study.体重指数作为COVID-19主要预后影响因素:一项埃及多中心研究。
Infect Drug Resist. 2023 Sep 8;16:5985-6004. doi: 10.2147/IDR.S426440. eCollection 2023.
6
Massive Airway Hemorrhage in Severe COVID-19 and the Role of Endotracheal Tube Clamping.重症新型冠状病毒肺炎中的大量气道出血及气管插管钳夹的作用
Infect Drug Resist. 2023 Apr 21;16:2387-2393. doi: 10.2147/IDR.S378408. eCollection 2023.
7
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms.新型冠状病毒肺炎的神经并发症及影响:症状与可能的机制
Brain Hemorrhages. 2023 Sep;4(3):154-173. doi: 10.1016/j.hest.2023.02.001.
8
"Day 25": a temporal indicator of stabilization of mortality risk among COVID-19 patients with high viral load.“第25天”:病毒载量高的COVID-19患者死亡风险稳定的一个时间指标。
Trop Med Health. 2022 Dec 9;50(1):92. doi: 10.1186/s41182-022-00483-8.
9
The Associations of Iron Related Biomarkers with Risk, Clinical Severity and Mortality in SARS-CoV-2 Patients: A Meta-Analysis.铁相关生物标志物与 SARS-CoV-2 患者风险、临床严重程度和死亡率的关联:一项荟萃分析。
Nutrients. 2022 Aug 19;14(16):3406. doi: 10.3390/nu14163406.
10
Predicting the Disease Severity of Virus Infection.预测病毒感染的疾病严重程度。
Adv Exp Med Biol. 2022;1368:111-139. doi: 10.1007/978-981-16-8969-7_6.

本文引用的文献

1
Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients.COVID-19患者的重症指标及死亡预测因素
Infect Drug Resist. 2020 Jun 26;13:1995-2000. doi: 10.2147/IDR.S261159. eCollection 2020.
2
Diabetes and metabolic syndrome as risk factors for COVID-19.糖尿病和代谢综合征作为新冠病毒疾病的风险因素。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):671-677. doi: 10.1016/j.dsx.2020.05.013. Epub 2020 May 8.
3
Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.对于预测新冠病毒疾病(COVID-19)患者的死亡率而言,呼吸困难而非发热是一个风险因素。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.013. Epub 2020 May 15.
4
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.COPD 与 COVID-19 患者吸烟的流行率、严重程度和死亡率:一项快速系统评价和荟萃分析。
PLoS One. 2020 May 11;15(5):e0233147. doi: 10.1371/journal.pone.0233147. eCollection 2020.
5
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
6
Estimation of COVID-19 burden in Egypt.埃及新冠疫情负担评估。
Lancet Infect Dis. 2020 Aug;20(8):896-897. doi: 10.1016/S1473-3099(20)30319-4. Epub 2020 Apr 27.
7
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
8
Chest CT in patients suspected of COVID-19 infection: A reliable alternative for RT-PCR.疑似新型冠状病毒肺炎感染患者的胸部CT检查:逆转录聚合酶链反应的可靠替代方法
Am J Emerg Med. 2020 Dec;38(12):2730-2732. doi: 10.1016/j.ajem.2020.04.016. Epub 2020 Apr 8.
9
Therapeutic strategies for critically ill patients with COVID-19.新型冠状病毒肺炎危重症患者的治疗策略
Ann Intensive Care. 2020 Apr 20;10(1):45. doi: 10.1186/s13613-020-00661-z.
10
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.